As of 2025-06-28, the Relative Valuation of GlaxoSmithKline PLC (GSK.L) is 1,459.31 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1,405.50 GBP, the upside of GlaxoSmithKline PLC based on Relative Valuation is 3.8%.
The range of the Relative Valuation is 1,382.62 - 1,621.38 GBP.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 22.1x | 20.2x |
| Forward P/E multiples | 19.9x - 23.4x | 21.6x |
| Fair Price | 1,382.62 - 1,621.38 | 1,459.31 |
| Upside | -1.6% - 15.4% | 3.8% |
| Date | P/E |
| 2025-06-27 | 19.95 |
| 2025-06-26 | 19.80 |
| 2025-06-25 | 19.80 |
| 2025-06-24 | 20.02 |
| 2025-06-23 | 19.92 |
| 2025-06-20 | 19.91 |
| 2025-06-19 | 20.37 |
| 2025-06-18 | 20.58 |
| 2025-06-17 | 21.01 |
| 2025-06-16 | 21.09 |
| 2025-06-13 | 21.46 |
| 2025-06-12 | 22.00 |
| 2025-06-11 | 21.62 |
| 2025-06-10 | 21.41 |
| 2025-06-09 | 21.42 |
| 2025-06-06 | 21.48 |
| 2025-06-05 | 21.46 |
| 2025-06-04 | 21.21 |
| 2025-06-03 | 21.08 |
| 2025-06-02 | 21.54 |
| 2025-05-30 | 21.39 |
| 2025-05-29 | 20.67 |
| 2025-05-28 | 20.53 |
| 2025-05-27 | 20.56 |
| 2025-05-23 | 20.24 |
| 2025-05-22 | 20.28 |
| 2025-05-21 | 20.30 |
| 2025-05-20 | 20.09 |
| 2025-05-19 | 19.82 |
| 2025-05-16 | 19.80 |
| 2025-05-15 | 19.34 |
| 2025-05-14 | 19.31 |
| 2025-05-13 | 19.28 |
| 2025-05-12 | 19.87 |
| 2025-05-09 | 19.56 |
| 2025-05-08 | 19.36 |
| 2025-05-07 | 19.58 |
| 2025-05-06 | 20.58 |
| 2025-05-02 | 20.56 |
| 2025-05-01 | 20.77 |
| 2025-04-30 | 21.06 |
| 2025-04-29 | 20.33 |
| 2025-04-28 | 20.00 |
| 2025-04-25 | 19.72 |
| 2025-04-24 | 19.79 |
| 2025-04-23 | 19.58 |
| 2025-04-22 | 19.34 |
| 2025-04-17 | 18.97 |
| 2025-04-16 | 19.10 |
| 2025-04-15 | 19.11 |